![]() |
![]() |
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
February 23-27, 2009 | |||||
FDA Official and Title |
Date |
Location |
Other FDA Participants |
Non-FDA Participants |
Subject |
---|---|---|---|---|---|
Frank Torti, Acting Commissioner | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Murray Lumpkin, Deputy Commissioner for International and Special Programs | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Randall Lutter, Deputy Commissioner for Policy | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Janet Woodcock, Director, Center for Drug Evaluation and Research | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs | 2/24/09 | Rockville, Maryland | David Elder, George Salem, Richard Garwood | Susan de Mars, Roger L. Williams, Brian Hendrix, Ken Alexander, Steve Lane (USP) | Discuss the CRADA between FDA and USP |
Jesse Goodman, Director, Center for Biologics Evaluation and Research | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Daniel Schultz, Director, Center for Devices and Radiological Health | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Stephen Sundlof, Center for Food Safety and Applied Nutrition | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Bernadette Dunham, Director, Center for Veterinary Medicine | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
William Slikker, Director, National Center for Toxicological Research | 2/23/09 through 2/27/09 | N/A | N/A | N/A | No significant meetings |
Jeffrey M. Senger, Acting Chief Counsel | 2/25/2009 | FDA/Rockville | Kim Dettelbach, Julie Finegan, Eric Blumberg (OCC) | Robert Dormer, Michelle Butler (Hyman, Phelps & McNamara) | ANDA Approval Issues |